Skip to content
etf.net

ROM vs XBIX

ProShares Ultra Technology

ROMANYSE Arca

Corgi U.S. Biotech 2x Daily ETF

XBIXCCboe

Overlap

Expense ratio

XBIX −0.48pt a year

ROM0.93%XBIX0.45%

Avg volume · 30D

ROM 29.8×the volume

ROM47.7KXBIX1.6K

ROM vs XBIX Performance

Jul 31, 2026 – Oct 30, 2026

+2.0%ROM+6.5%XBIX

Jul 31, 2026 to Oct 30, 2026. ROM +2.0%. XBIX +6.5%. Use the arrow keys to read each point.−10%20%30%Jul 2026Sep 2026Oct 2026
Expense ratio
ROM 0.93%
XBIX 0.45%, better
Fund size
ROM $1.15B
XBIX $0
1Y total return
ROM +26.5%
XBIX No data
Yield (12M)
ROM 0.03%
XBIX No data
Holdings
ROM 85
XBIX 1
Avg volume (30D)
ROM 47.7K sh, better
XBIX 1.6K sh
NAV per share
ROM $132.18
XBIX $34.24
52W range

ETF.net Grade

ROM: Cost 70, Risk 56, Mission not scored, Tradability 88, Holdings not scored, Durability 81. XBIX: Cost 86, Risk 62, Mission not scored, Tradability 28, Holdings not scored, Durability 20.
Pillar letters and Scores for ROM, XBIX, with each pillar’s weight
PillarROMXBIX
Cost30% weightA70A86Higher
Mission25% weightNot scoredNot scored
Risk15% weightB56B62Higher
Tradability15% weightA88HigherD28
Holdings10% weightNot scoredNot scored
Durability5% weightA81HigherF20

Rank among Leveraged Long (2x & Other) funds

How we build Categories ›
Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. ROM and XBIX are both graded against the same 95 Leveraged Long (2x & Other) funds, so their Grades compare head to head.

Leveraged Long (2x & Other)⁠

Category · 95 funds
See all 95 ›

ROM ranks 3rd and XBIX 37th of 95 funds in the Leveraged Long (2x & Other) Category.

  1. Rank 1AQLDProShares Ultra QQQScore 77
  2. Rank 2AUYGProShares Ultra FinancialsScore 74
  3. Rank 3AROMProShares Ultra TechnologyScore 71
  4. Rank 4BDDMProShares Ultra Dow30Score 69
  5. Rank 37CWXCorgi All World 2x Daily ETFScore 40
  6. Rank 37CXBIXCorgi U.S. Biotech 2x Daily ETFScore 40
  7. Rank 37CXCOMCorgi All Commodities 2x Daily ETFScore 40

Our read on each fund

ETF.net Research

ROMAProShares Ultra Technology

XBIXCCorgi U.S. Biotech 2x Daily ETF

In short

ROM The original 2x tech trade. Since 2007, ROM has aimed at twice the daily move of the S&P 500's technology sector: a double dose in a category now stacked with triples.

XBIX No data

Stated mandate

ROM ROM seeks daily investment results, before fees and expenses, corresponding to twice the daily performance of the S&P Technology Select Sector SM Index.

XBIX No data

Why people hold it

  • ROM Two times, not three. A 2x daily target means smaller swings and less compounding drag than a 3x fund chasing the same sector.sec.gov
  • Live since January 2007, so it has run through the 2008 crash and the full tech cycle since. Long mileage is rare in geared funds.
  • 0.93% a year, flat, with no waiver propping it up. Peer QLD runs 0.89%, but only net of a waiver through September 30, 2027.
  • One of the strongest implementations in the leveraged-bull pack, from an issuer that has run geared funds since the category's early days.proshares.com

XBIX No data

Worth knowing

  • ROM The 2x target resets at each close, so results over weeks or months depend on the path the sector takes, not just where it ends up.sec.govproshares.com
  • Trades thinner than the category's headline names, so spreads and limit orders matter, especially in size.
  • About 80 tech names from the S&P 500. That is one concentrated sector bet, doubled, in both directions.

XBIX No data

Full ROM profile⁠

Full XBIX profile⁠

ROM vs XBIX Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

ROM vs XBIX Cost

Overpaying ROM vs XBIX

$8,498

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • ROM 0.93%

    $17,539

  • XBIX 0.45%

    $9,041

$10,000
30 years

Cost over time

  • ROM 0.93%
  • XBIX 0.45%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K$20K051015202530ROM $17,539XBIX $9,041

Year by year

YearROMXBIXOverpaying
10$1,644$812$832
20$6,199$3,128$3,071
30$17,539$9,041$8,498

Expense ratio

  • 0.93%ROM
  • 0.45%XBIX, cheaper
  • Middle half of Leveraged Long (2x & Other) funds
  • Median 0.95%

XBIX 3rd cheapest of 95 funds

ROM 29th cheapest of 95 funds

ROM vs XBIX Dividends

Last 12 months to Oct 30, 2026
Yield (12M)
ROM 0.03%
XBIX No data
Payout (12M)
ROM $0.04
XBIX None
Last payment
ROM $0.02
XBIX No data
Ex-dividend
ROM Mar 25, 2026
XBIX No data
Paid on
ROM Mar 31, 2026
XBIX No data
Frequency
ROM Quarterly
XBIX No data

Distribution history

Per share, 2017 to 2026, same scale for both

ROMQuarterly · 19 paymentsAll ROM payments⁠
One bar per payment. 19 payments from 2017 to 2026 YTD. Mar 22, 2017 $0.0015; Dec 26, 2017 $0.0075; Mar 21, 2018 $0.0064; Jun 20, 2018 $0.006; Dec 26, 2018 $0.02; Mar 20, 2019 $0.01; Jun 25, 2019 $0.0043; Dec 24, 2019 $0.01; Mar 25, 2020 $0.02; Dec 20, 2023 $0.0042; Mar 20, 2024 $0.01; Jun 26, 2024 $0.04; Sep 25, 2024 $0.06; Dec 23, 2024 $0.03; Mar 26, 2025 $0.02; Jun 25, 2025 $0.14; Sep 24, 2025 $0.05; Dec 24, 2025 $0.02; Mar 25, 2026 $0.02. Use the arrow keys to read each point.$0$0.102017202020232026YTD
XBIXAll XBIX payments⁠

No distribution history available.

ROM vs XBIX Risk

Fall from peak · 5 years

This chart needs five years of history for both funds.

Risk facts

VolatilityStd dev, 3 years
ROM 49.3%XBIX No data
Return per unit of riskSharpe ratio, 3 years
ROM 0.97XBIX No data
Worst fallMax drawdown, 5 years
ROM −67.6%XBIX No data
Market sensitivityBeta, 5 years
ROM 3.09XBIX 0.00

Popular comparisons

  • ROMAvsQLDA

    ProShares Ultra Technology · ProShares Ultra QQQ

    Expense ratio
    0.93% · 0.89%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • XBIXCvsQLDA

    Corgi U.S. Biotech 2x Daily ETF · ProShares Ultra QQQ

    Expense ratio
    0.45% · 0.89%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • ROMAvsUYGA

    ProShares Ultra Technology · ProShares Ultra Financials

    Expense ratio
    0.93% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • XBIXCvsUYGA

    Corgi U.S. Biotech 2x Daily ETF · ProShares Ultra Financials

    Expense ratio
    0.45% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • ROMAvsDDMB

    ProShares Ultra Technology · ProShares Ultra Dow30

    Expense ratio
    0.93% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • XBIXCvsDDMB

    Corgi U.S. Biotech 2x Daily ETF · ProShares Ultra Dow30

    Expense ratio
    0.45% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.